Brief: Cue Biopharma Posts Quarterly Loss Per Share Of $0.41
May 17 (Reuters) - Cue Biopharma Inc CUE.O :
* CUE BIOPHARMA REPORTS FIRST QUARTER 2021 RESULTS, RECENT
UPDATES
OF CUE-101 PHASE 1 DOSE ESCALATION STUDY, PLATFORM PROGRESS AND
BUSINESS HIGHLIGHTS
* CUE BIOPHARMA - QTRLY LOSS PER SHARE $0.41
Source text for Eikon: ID:nGNX5H79r3
Further company coverage: CUE.O
((Reuters.Briefs@thomsonreuters.com;))